{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T15:06:38Z","timestamp":1790003198961,"version":"4.0.1"},"reference-count":36,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2011,7,1]],"date-time":"2011-07-01T00:00:00Z","timestamp":1309478400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Molecular and Cellular Cardiology"],"published-print":{"date-parts":[[2011,7]]},"DOI":"10.1016\/j.yjmcc.2011.03.001","type":"journal-article","created":{"date-parts":[[2011,4,15]],"date-time":"2011-04-15T19:08:18Z","timestamp":1302894498000},"page":"4-15","source":"Crossref","is-referenced-by-count":28,"title":["Cyclosporine attenuates cardiomyocyte hypertrophy induced by RAF1 mutants in Noonan and LEOPARD syndromes"],"prefix":"10.1016","volume":"51","author":[{"given":"Perundurai S.","family":"Dhandapany","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Fabris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rahul","family":"Tonk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ardo","family":"Illaste","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ioannis","family":"Karakikes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehran","family":"Sorourian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jipo","family":"Sheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger J.","family":"Hajjar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Tartaglia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric A.","family":"Sobie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Djamel","family":"Lebeche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce D.","family":"Gelb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.yjmcc.2011.03.001_bb0005","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/nrm1983","article-title":"Regulation of cardiac hypertrophy by intracellular signalling pathways","volume":"7","author":"Heineke","year":"2006","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"3","key":"10.1016\/j.yjmcc.2011.03.001_bb0010","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.cardiores.2004.01.021","article-title":"Calcineurin\u2013NFAT signaling regulates the cardiac hypertrophic response in coordination with the MAPKs","volume":"63","author":"Molkentin","year":"2004","journal-title":"Cardiovasc Res"},{"issue":"8","key":"10.1016\/j.yjmcc.2011.03.001_bb0015","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1038\/ng2073","article-title":"Gain-of-function RAF1 mutations cause Noonan and LEOPARD syndromes with hypertrophic cardiomyopathy","volume":"39","author":"Pandit","year":"2007","journal-title":"Nat Genet"},{"issue":"8","key":"10.1016\/j.yjmcc.2011.03.001_bb0020","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1038\/ng2078","article-title":"Germline gain-of-function mutations in RAF1 cause Noonan syndrome","volume":"39","author":"Razzaque","year":"2007","journal-title":"Nat Genet"},{"issue":"2","key":"10.1016\/j.yjmcc.2011.03.001_bb0025","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.yjmcc.2008.05.006","article-title":"Role of resistin in cardiac contractility and hypertrophy","volume":"45","author":"Kim","year":"2008","journal-title":"J Mol Cell Cardiol"},{"issue":"6","key":"10.1016\/j.yjmcc.2011.03.001_bb0030","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/j.molcel.2008.08.026","article-title":"CRAF autophosphorylation of serine 621 is required to prevent its proteasome-mediated degradation","volume":"31","author":"Noble","year":"2008","journal-title":"Mol Cell"},{"issue":"11","key":"10.1016\/j.yjmcc.2011.03.001_bb0035","doi-asserted-by":"crossref","first-page":"2757","DOI":"10.1093\/emboj\/20.11.2757","article-title":"Activated MEK5 induces serial assembly of sarcomeres and eccentric cardiac hypertrophy","volume":"20","author":"Nicol","year":"2001","journal-title":"EMBO J"},{"issue":"11","key":"10.1016\/j.yjmcc.2011.03.001_bb0040","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1161\/CIRCRESAHA.109.200741","article-title":"ASK1 regulates cardiomyocyte death but not hypertrophy in transgenic mice","volume":"105","author":"Liu","year":"2009","journal-title":"Circ Res"},{"issue":"10","key":"10.1016\/j.yjmcc.2011.03.001_bb0045","doi-asserted-by":"crossref","first-page":"3785","DOI":"10.1128\/MCB.26.10.3785-3797.2006","article-title":"Direct interaction and reciprocal regulation between ASK1 and calcineurin\u2013NFAT control cardiomyocyte death and growth","volume":"26","author":"Liu","year":"2006","journal-title":"Mol Cell Biol"},{"issue":"14","key":"10.1016\/j.yjmcc.2011.03.001_bb0050","doi-asserted-by":"crossref","first-page":"7783","DOI":"10.1073\/pnas.141224398","article-title":"Raf-1 promotes cell survival by antagonizing apoptosis signal-regulating kinase 1 through a MEK-ERK independent mechanism","volume":"98","author":"Chen","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"issue":"3","key":"10.1016\/j.yjmcc.2011.03.001_bb0055","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1128\/MCB.25.3.865-878.2005","article-title":"Direct and indirect interactions between calcineurin\u2013NFAT and MEK1-extracellular signal-regulated kinase 1\/2 signaling pathways regulate cardiac gene expression and cellular growth","volume":"25","author":"Sanna","year":"2005","journal-title":"Mol Cell Biol"},{"issue":"10","key":"10.1016\/j.yjmcc.2011.03.001_bb0060","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1172\/JCI200317295","article-title":"Targeted inhibition of p38 MAPK promotes hypertrophic cardiomyopathy through upregulation of calcineurin\u2013NFAT signaling","volume":"111","author":"Braz","year":"2003","journal-title":"J Clin Invest"},{"issue":"22","key":"10.1016\/j.yjmcc.2011.03.001_bb0065","doi-asserted-by":"crossref","first-page":"6414","DOI":"10.1093\/emboj\/20.22.6414","article-title":"Activation of MEF2 by muscle activity is mediated through a calcineurin-dependent pathway","volume":"20","author":"Wu","year":"2001","journal-title":"EMBO J"},{"key":"10.1016\/j.yjmcc.2011.03.001_bb0070","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1196\/annals.1420.008","article-title":"Cardiac cell hypertrophy in vitro: role of calcineurin\/NFAT as Ca2+ signal integrators","volume":"1123","author":"Colella","year":"2008","journal-title":"Ann NY Acad Sci"},{"issue":"8","key":"10.1016\/j.yjmcc.2011.03.001_bb0075","doi-asserted-by":"crossref","first-page":"2859","DOI":"10.1073\/pnas.0712316105","article-title":"Ca2+ oscillation frequency decoding in cardiac cell hypertrophy: role of calcineurin\/NFAT as Ca2+ signal integrators","volume":"105","author":"Colella","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"issue":"13","key":"10.1016\/j.yjmcc.2011.03.001_bb0080","doi-asserted-by":"crossref","first-page":"7725","DOI":"10.1074\/jbc.273.13.7725","article-title":"The low molecular weight GTPase Rho regulates myofibril formation and organization in neonatal rat ventricular myocytes. Involvement of Rho kinase","volume":"273","author":"Hoshijima","year":"1998","journal-title":"J Biol Chem"},{"issue":"39","key":"10.1016\/j.yjmcc.2011.03.001_bb0085","doi-asserted-by":"crossref","first-page":"23173","DOI":"10.1074\/jbc.270.39.23173","article-title":"Ventricular expression of a MLC-2v-ras fusion gene induces cardiac hypertrophy and selective diastolic dysfunction in transgenic mice","volume":"270","author":"Hunter","year":"1995","journal-title":"J Biol Chem"},{"issue":"23","key":"10.1016\/j.yjmcc.2011.03.001_bb0090","doi-asserted-by":"crossref","first-page":"6341","DOI":"10.1093\/emboj\/19.23.6341","article-title":"The MEK1-ERK1\/2 signaling pathway promotes compensated cardiac hypertrophy in transgenic mice","volume":"19","author":"Bueno","year":"2000","journal-title":"EMBO J"},{"issue":"9","key":"10.1016\/j.yjmcc.2011.03.001_bb0095","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1161\/01.RES.0000041029.97988.E9","article-title":"Ras\/Erk signaling is essential for activation of protein synthesis by Gq protein-coupled receptor agonists in adult cardiomyocytes","volume":"91","author":"Wang","year":"2002","journal-title":"Circ Res"},{"issue":"4","key":"10.1016\/j.yjmcc.2011.03.001_bb0100","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1161\/01.HYP.0000062881.36813.7A","article-title":"Long-acting Ca2+ blockers prevent myocardial remodeling induced by chronic NO inhibition in rats","volume":"41","author":"Sanada","year":"2003","journal-title":"Hypertension"},{"issue":"6","key":"10.1016\/j.yjmcc.2011.03.001_bb0105","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1161\/01.CIR.0000138190.50127.6A","article-title":"Raf-1 kinase is required for cardiac hypertrophy and cardiomyocyte survival in response to pressure overload","volume":"110","author":"Harris","year":"2004","journal-title":"Circulation"},{"issue":"35","key":"10.1016\/j.yjmcc.2011.03.001_bb0110","doi-asserted-by":"crossref","first-page":"14074","DOI":"10.1073\/pnas.0610906104","article-title":"Genetic inhibition of cardiac ERK1\/2 promotes stress-induced apoptosis and heart failure but has no effect on hypertrophy in vivo","volume":"104","author":"Purcell","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"issue":"2","key":"10.1016\/j.yjmcc.2011.03.001_bb0115","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1161\/CIRCRESAHA.110.231514","article-title":"Extracellular signal-regulated kinases 1 and 2 regulate the balance between eccentric and concentric cardiac growth","volume":"108","author":"Kehat","year":"2011","journal-title":"Circ Res"},{"issue":"5","key":"10.1016\/j.yjmcc.2011.03.001_bb0120","doi-asserted-by":"crossref","first-page":"3524","DOI":"10.1074\/jbc.M004275200","article-title":"Ras regulates NFAT3 activity in cardiac myocytes","volume":"276","author":"Ichida","year":"2001","journal-title":"J Biol Chem"},{"issue":"12","key":"10.1016\/j.yjmcc.2011.03.001_bb0125","doi-asserted-by":"crossref","first-page":"4353","DOI":"10.1172\/JCI43910","article-title":"Activation of multiple signaling pathways causes developmental defects in mice with a Noonan syndrome\u2013associated Sos1 mutation","volume":"120","author":"Chen","year":"2010","journal-title":"J Clin Invest"},{"issue":"2","key":"10.1016\/j.yjmcc.2011.03.001_bb0130","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0092-8674(00)81573-1","article-title":"A calcineurin-dependent transcriptional pathway for cardiac hypertrophy","volume":"93","author":"Molkentin","year":"1998","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.yjmcc.2011.03.001_bb0135","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.yjmcc.2008.09.002","article-title":"With great power comes great responsibility: using mouse genetics to study cardiac hypertrophy and failure","volume":"46","author":"Molkentin","year":"2009","journal-title":"J Mol Cell Cardiol."},{"issue":"12","key":"10.1016\/j.yjmcc.2011.03.001_bb0140","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1136\/jmg.2007.050450","article-title":"Cardio-facio-cutaneous and Noonan syndromes due to mutations in the RAS\/MAPK signalling pathway: genotype-phenotype relationships and overlap with Costello syndrome","volume":"44","author":"Nava","year":"2007","journal-title":"J Med Genet"},{"issue":"4","key":"10.1016\/j.yjmcc.2011.03.001_bb0145","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1136\/jmg.2007.054460","article-title":"Further delineation of cardio-facio-cutaneous syndrome: clinical features of 38 individuals with proven mutations","volume":"45","author":"Armour","year":"2008","journal-title":"J Med Genet"},{"issue":"5765","key":"10.1016\/j.yjmcc.2011.03.001_bb0150","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1126\/science.1124642","article-title":"Germline mutations in genes within the MAPK pathway cause cardio-facio-cutaneous syndrome","volume":"311","author":"Rodriguez-Viciana","year":"2006","journal-title":"Science"},{"issue":"6","key":"10.1016\/j.yjmcc.2011.03.001_bb0155","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1038\/ejhg.2008.256","article-title":"Spectrum of MEK1 and MEK2 gene mutations in cardio-facio-cutaneous syndrome and genotype-phenotype correlations","volume":"17","author":"Dentici","year":"2009","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.yjmcc.2011.03.001_bb0160","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/S0076-6879(07)38019-1","article-title":"Biochemical characterization of novel germline BRAF and MEK mutations in cardio-facio-cutaneous syndrome","volume":"438","author":"Rodriguez-Viciana","year":"2008","journal-title":"Meth Enzymol"},{"issue":"11\u201312","key":"10.1016\/j.yjmcc.2011.03.001_bb0165","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1007\/s10038-008-0343-6","article-title":"PTPN11, SOS1, KRAS, and RAF1 gene analysis, and genotype-phenotype correlation in Korean patients with Noonan syndrome","volume":"53","author":"Ko","year":"2008","journal-title":"J Hum Genet"},{"issue":"3","key":"10.1016\/j.yjmcc.2011.03.001_bb0170","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1002\/humu.21187","article-title":"Molecular and clinical analysis of RAF1 in Noonan syndrome and related disorders: dephosphorylation of serine 259 as the essential mechanism for mutant activation","volume":"31","author":"Kobayashi","year":"2010","journal-title":"Hum Mutat"},{"issue":"1","key":"10.1016\/j.yjmcc.2011.03.001_bb0175","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/ajmg.a.31047","article-title":"HRAS mutation analysis in Costello syndrome: genotype and phenotype correlation","volume":"140","author":"Gripp","year":"2006","journal-title":"Am J Med Genet A"},{"issue":"1","key":"10.1016\/j.yjmcc.2011.03.001_bb0180","doi-asserted-by":"crossref","first-page":"H424","DOI":"10.1152\/ajpheart.00110.2003","article-title":"Sarcoplasmic reticulum calcium defect in Ras-induced hypertrophic cardiomyopathy heart","volume":"286","author":"Zheng","year":"2004","journal-title":"Am J Physiol Heart Circ Physiol"}],"container-title":["Journal of Molecular and Cellular Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022282811000964?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022282811000964?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,3]],"date-time":"2018-12-03T13:51:59Z","timestamp":1543845119000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022282811000964"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,7]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,7]]}},"alternative-id":["S0022282811000964"],"URL":"https:\/\/doi.org\/10.1016\/j.yjmcc.2011.03.001","relation":{},"ISSN":["0022-2828"],"issn-type":[{"value":"0022-2828","type":"print"}],"subject":[],"published":{"date-parts":[[2011,7]]}}}